- SOHO •
- 4 September, 2024 •
- •
Phase 1b Open-Label Study of Loncastuximab Tesirine in Combination With Other Anticancer Agents in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7). Clinical Lymphoma, Myeloma & Leukemia
Emily C. Ayers, Julien Depaus, Fritz Offner, Marie Hu, Craig Okada, Andrzej Urban, Andrew Niewiarowski, Erica Rave, Mary Laughlin, Juan Pablo Alderuccio
Available materials